TipRanks
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:9989 full AI Analyst Report?

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ratios

2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Ratios

HK:9989's free cash flow for Q2 2026 was ¥0.34. For the 2026 fiscal year, HK:9989's free cash flow was decreased by ¥ and operating cash flow was ¥0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.31 2.31 2.60 2.13 2.22
Quick Ratio
 1.33 1.19 1.14 0.79 0.99
Cash Ratio
 0.38 0.34 0.46 0.37 0.38
Solvency Ratio
 0.16 0.16 0.19 -0.06 0.12
Operating Cash Flow Ratio
 0.42 0.43 0.59 0.08 -0.14
Short-Term Operating Cash Flow Coverage
 0.58 0.97 1.19 0.21 -0.32
Net Current Asset Value
¥ 4.74B¥ 4.60B¥ 4.48B¥ 3.39B¥ 3.98B
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.13 0.17 0.20 0.31
Debt-to-Equity Ratio
 0.25 0.18 0.25 0.32 0.53
Debt-to-Capital Ratio
 0.20 0.15 0.20 0.24 0.34
Long-Term Debt-to-Capital Ratio
 <0.01 0.02 0.08 0.13 0.16
Financial Leverage Ratio
 1.38 1.38 1.43 1.61 1.69
Debt Service Coverage Ratio
 0.28 0.43 0.55 -0.10 0.48
Interest Coverage Ratio
 8.46 8.90 5.25 -1.07 4.83
Debt to Market Cap
 0.24 0.30 0.54 0.78 0.68
Interest Debt Per Share
 2.03 1.49 2.13 2.73 4.57
Net Debt to EBITDA
 1.69 0.90 1.08 -5.82 3.15
Profitability Margins
Gross Profit Margin
33.81%31.81%33.26%33.06%32.61%
EBIT Margin
5.63%8.65%16.43%-12.95%14.88%
EBITDA Margin
15.85%15.45%22.70%-6.09%19.17%
Operating Profit Margin
9.22%11.61%14.04%-4.37%15.86%
Pretax Profit Margin
3.80%7.34%13.75%-17.05%11.59%
Net Profit Margin
3.87%6.38%12.25%-14.38%10.16%
Continuous Operations Profit Margin
3.75%6.25%11.83%-14.73%9.99%
Net Income Per EBT
101.91%86.88%89.05%84.37%87.66%
EBT Per EBIT
41.18%63.25%97.97%389.87%73.11%
Return on Assets (ROA)
1.23%2.10%3.73%-4.08%3.49%
Return on Equity (ROE)
1.67%2.90%5.32%-6.57%5.91%
Return on Capital Employed (ROCE)
3.86%5.02%5.43%-1.67%7.45%
Return on Invested Capital (ROIC)
3.10%3.75%4.12%-1.28%5.55%
Return on Tangible Assets
1.45%2.50%4.44%-4.78%4.07%
Earnings Yield
1.40%5.09%11.85%-16.46%10.28%
Efficiency Ratios
Receivables Turnover
 3.19 3.90 4.13 7.27 4.07
Payables Turnover
 15.05 14.53 11.76 12.06 11.29
Inventory Turnover
 0.88 0.84 0.65 0.55 0.71
Fixed Asset Turnover
 2.34 2.29 1.99 2.07 2.89
Asset Turnover
 0.32 0.33 0.30 0.28 0.34
Working Capital Turnover Ratio
 1.01 0.99 0.92 0.88 1.12
Cash Conversion Cycle
 502.89 502.98 615.88 686.23 575.16
Days of Sales Outstanding
 114.40 93.67 88.32 50.22 89.77
Days of Inventory Outstanding
 412.74 434.43 558.59 666.27 517.72
Days of Payables Outstanding
 24.25 25.12 31.04 30.26 32.33
Operating Cycle
 527.14 528.10 646.92 716.50 607.49
Cash Flow Ratios
Operating Cash Flow Per Share
 1.13 1.17 1.50 0.27 -0.52
Free Cash Flow Per Share
 1.08 1.08 1.36 -0.03 -0.67
CapEx Per Share
 0.05 0.08 0.14 0.30 0.15
Free Cash Flow to Operating Cash Flow
 0.95 0.93 0.91 -0.12 1.29
Dividend Paid and CapEx Coverage Ratio
 5.09 3.10 6.05 0.46 -1.60
Capital Expenditure Coverage Ratio
 20.92 14.14 10.82 0.90 -3.40
Operating Cash Flow Coverage Ratio
 0.57 0.81 0.74 0.11 -0.12
Operating Cash Flow to Sales Ratio
 0.32 0.31 0.42 0.07 -0.11
Free Cash Flow Yield
12.88%23.18%36.49%-0.98%-13.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 70.56 19.50 8.45 -6.08 9.72
Price-to-Sales (P/S) Ratio
 2.34 1.25 1.03 0.87 0.99
Price-to-Book (P/B) Ratio
 1.21 0.57 0.45 0.40 0.57
Price-to-Free Cash Flow (P/FCF) Ratio
 7.76 4.31 2.74 -102.01 -7.23
Price-to-Operating Cash Flow Ratio
 8.70 4.01 2.49 11.95 -9.35
Price-to-Earnings Growth (PEG) Ratio
 -1.41 -0.43 -0.05 0.03 0.05
Price-to-Fair Value
 1.21 0.57 0.45 0.40 0.57
Enterprise Value Multiple
 16.48 9.01 5.63 -20.18 8.30
Enterprise Value
 13.69B 7.63B 6.75B 6.69B 11.40B
EV to EBITDA
 16.48 9.01 5.63 -20.18 8.30
EV to Sales
 2.61 1.39 1.28 1.23 1.59
EV to Free Cash Flow
 8.65 4.79 3.39 -143.36 -11.64
EV to Operating Cash Flow
 8.24 4.45 3.07 16.80 -15.07
Tangible Book Value Per Share
 6.47 6.44 6.43 6.25 6.46
Shareholders’ Equity Per Share
 8.13 8.20 8.28 8.12 8.39
Tax and Other Ratios
Effective Tax Rate
 0.01 0.15 0.14 0.14 0.14
Revenue Per Share
 3.57 3.73 3.60 3.71 4.88
Net Income Per Share
 0.14 0.24 0.44 -0.53 0.50
Tax Burden
 1.02 0.87 0.89 0.84 0.88
Interest Burden
 0.67 0.85 0.84 1.32 0.78
Research & Development to Revenue
 0.04 0.04 0.04 0.03 0.04
SG&A to Revenue
 0.10 0.09 0.09 0.03 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 8.19 5.00 3.51 -0.50 -1.06
Currency in CNY